Sunnyvale, CA (PRWEB) June 06, 2011
Freeslate, Inc., the leading provider of high throughput research solutions that enable dramatic gains in R&D productivity and innovation, today announced the release of Automation Studio 8.3 software, a key component of its powerful Lab Execution and Analysis (LEA) software suite. Automation Studio improves R&D productivity by automating and controlling multiple laboratory instruments with a single software interface. The release of version 8.3 introduces a new high-performance framework for managing communications with Freeslate’s Core Module 3 (CM3) robotics platform giving researchers increased performance and control of their high throughput experiments.
The CM3 is a highly flexible platform that utilizes the experimental design, workflow automation and data management tools of LEA software to allow researchers to leverage a single automated instrument to prepare, process and test an array of complex mixtures and samples.
“The release of Automation Studio 8.3 gives customers powerful new capabilities when running experiments on our Core Module 3,” stated John Senaldi, president and chief executive officer of Freeslate. “By optimizing the performance of the system, the software allows customers to experience greater confidence and efficiency, increasing their productivity.”
Along with enhanced instrument performance, Automation Studio 8.3 also comes with a number of new features that provide researchers with a deeper understanding of what is happening during an experiment. New features include better display and monitoring of experiment process conditions, more sophisticated safety features, and dynamic parsers that can save data while an experiment is in progress. The new version now supports the Microsoft® Windows 7 operating system and Microsoft® Office 2010.
Freeslate’s LEA software suite also includes Library Studio 8.3, which was released earlier this year. Library Studio allows scientists to design complex experiments for a variety of materials development applications, including protein formulation, pharmaceutical API salt selection and polymorph screening, polymer formulation, home and personal care products, and catalyst synthesis.
Freeslate is a privately held company that provides products and related services for high throughput research. Based on its proprietary laboratory automation platforms, high throughput pressure reactors, and integrated Lab Execution and Analysis (LEA) software suite, the company enables dramatic gains in its customers’ productivity and innovation by delivering seamlessly integrated automation solutions. Freeslate leverages its scientific expertise through its team of Ph.D. scientists, engineers, and software developers with directly relevant experience in the industries it serves. Collaborating with customers for more than a decade, the business has provided high throughput research solutions for the pharmaceutical, chemical, energy, and consumer products industries. The company is headquartered in Sunnyvale, California, with direct sales and service in North America, Europe and Asia. For more information, visit http://www.freeslate.com.